3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Lymphoma
112
Lymphoma, Large B-Cell, Diffuse
77
Precursor Cell Lymphoblastic Leukemia-Lymphoma
67
Leukemia
47
Burkitt Lymphoma
45
Lymphoma, Non-Hodgkin
35
Lymphoma, Mantle-Cell
28
Lymphoma, Follicular
27
Hodgkin Disease
22
Neuroblastoma
19
Central Nervous System Neoplasms
19
Sarcoma
18
Lymphoma, B-Cell
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Lymphoma, Large-Cell, Immunoblastic
12
Lymphoma, T-Cell, Peripheral
11
Lymphoma, Large-Cell, Anaplastic
11
Neoplasms
10
Multiple Myeloma
10
Dendritic Cell Sarcoma, Interdigitating
10
Sarcoma, Ewing
9
Rhabdomyosarcoma
9
Retinoblastoma
9
Medulloblastoma
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Biphenotypic, Acute
8
Recurrence
7
Neuroectodermal Tumors, Primitive, Peripheral
7
Lymphoma, T-Cell
7
HIV Infections
7
Interventions
Etoposide
2
Carboplatin
2
Vincristine
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Drug Therapy
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Retinal Neoplasms
×
Vincristine
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled